Medical supplies contracts in Germany

299 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Glycopyrronium bromide, ATC R03BB06, for the period 01.11.2025 - 31.10.2026 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 603091-2025

€11 lot, 1 year

Sun 5 Sep12:00 in Berlin

312days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Follitropin beta, ATC G03GA06, for the period 01.11.2025 - 31.10.2027

DAK-Gesundheit, HamburgTED 603888-2025

€11 lot, 2 years

Sun 5 Sep12:00 in Berlin

312days

Conclusion of a non-exclusive discount agreement pursuant to Section 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Allergen extract from exclusively meadow foxtail pollen, ATC V01AA02, for the period 01.10.2026 – 31.10.2027

DAK-Gesundheit, HamburgTED 571536-2026

€11 lot, 13 months

Sun 5 Sep12:00 in Berlin

312days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substances Formoterol, Beclometasone, Glycopyrronium, for the period 01.11.25 - 31.10.26 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 606785-2025

€11 lot, 1 year

Sun 5 Sep12:00 in Berlin

312days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Sodium phenylbutyrate, ATC A16AX03, for the period 01.11.2025 - 31.10.2027

DAK-Gesundheit, HamburgTED 603012-2025

€11 lot, 2 years

Sun 5 Sep12:00 in Berlin

312days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Tiotropium bromide exclusively in the form of solution for inhalation, ATC R03BB04 for the period 01.11.25 - 31.10.27

DAK-Gesundheit, HamburgTED 604908-2025

€11 lot, 2 years

Sun 5 Sep12:00 in Berlin

312days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Lenograstim, ATC L03AA10 for the period 01.11.2025 - 31.10.2027

DAK-Gesundheit, HamburgTED 604678-2025

€11 lot, 2 years

Sun 5 Sep12:00 in Berlin

312days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Raltegravir, ATC J05AJ01 for the period 01.11.2025 - 31.10.2027

DAK-Gesundheit, HamburgTED 604976-2025

€11 lot, 2 years

Sun 5 Sep12:00 in Berlin

312days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Birch Pollen Allergen Extract exclusively Dafo SUT, ATC V01AA05 for the period 01.11.2025 - 31.10.2027

DAK-Gesundheit, HamburgTED 605005-2025

€11 lot, 2 years

Sun 5 Sep12:00 in Berlin

312days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Clobetasol exclusively in the form of foam, ATC D07AD01 for the period 01.11.2025 - 31.10.2027

DAK-Gesundheit, HamburgTED 604590-2025

€11 lot, 2 years

Sun 5 Sep12:00 in Berlin

312days

Conclusion of non-exclusive discount agreements pursuant to § 130a, paragraph 8 of the Social Code Book V (Open-House model)

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 836333-2025

value not stated8 lots

Fri 1 Oct12:00 in Berlin

338days

Conclusion of agreements for the economic supply of contrast media within an Open House model

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 608230-2025

value not stated19 lots

Fri 1 Oct12:00 in Berlin

338days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Aflibercept (excluding 114, 3 mg/ml), ATC S01LA05 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 685877-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

342days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Tocilizumab (infusion concentrate solution only), ATC L04AC07, for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 683790-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

342days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Natalizumab (excl. in the form of IFK), for the period 01.12.25 - 30.11.26 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 684299-2025

€11 lot, 1 year

Tue 5 Oct12:00 in Berlin

342days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Haloperidol (exclusively injection solution), ATC N05AD01 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 683809-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

342days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Doravirin, ATC J05AG06 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 685244-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

342days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Tocilizumab (exclusively pre-filled syringe and pre-filled pen), ATC L04AC07 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 683943-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

342days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Sumatriptan (excluding film-coated tablets and tablets), ATC N02CC01 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 684236-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

342days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Doravirin + Lamivudin + Tenofovirdisoproxilfumarat, ATC J05AR24 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 685134-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

342days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.